This inhibition was associated with a reduction in the expression of matrix metalloproteinases MMP-2 and MMP-9, and proteins related to epithelial–mesenchymal transition (EMT), indicating a broad impact on cancer cell aggressiveness. This evidence concerns the gene MMP2 and cancer.